Published in Gene Therapy Weekly, December 27th, 2007
SuperArray reports that 67.2 percent of their proprietary algorithm's designs suppress target gene expression by at least 70 percent in a statistically significant fashion. The RNAi Consortium, a resource used by many researchers and other commercial providers of RNA Interference, only reports that 31 to 38 percent of its designs knock down gene expression to the same extent 1,2. SuperArray...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.